Evidence map›Paper›PMID 32338542›Full record

ArticleBlood pressure2020

Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project.

Reinhold Kreutz, Sverre E Kjeldsen, Michel Burnier, Krzysztof Narkiewicz, Suzanne Oparil, Giuseppe Mancia

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Blood pressure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Timing of antihypertensive medication (bedtimeFrontiers in pharmacology · 2026
    Pooled it
  2. Chronotherapy for Hypertension: A Meta-Analysis and Systematic Review of RCTs.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Pooled it
  3. Evening versus morning dosing regimen drug therapy for hypertension.The Cochrane database of systematic reviews · 2024
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Advances in the Treatment Strategies in Hypertension: Present and Future.Journal of cardiovascular development and disease · 2022
    Review
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Reinhold KreutzDepartment of Clinical Pharmacology and Toxicology, Charité University Medicine, Berlin, Germany.
Sverre E KjeldsenDepartment of Cardiology, University of Oslo, Ullevaal Hospital, Oslo Norway.
Michel BurnierService of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Krzysztof NarkiewiczDepartment of Hypertension and Diabetology, Medical University of Gdansk, Poland.
Suzanne OparilVascular Biology and Hypertension Program, Department of Medicine, University of Alabama at Birmingham, AL, USA.
Giuseppe ManciaUniversity of Milano-Bicocca, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiovascular DiseasesHypertensionAntihypertensive AgentsBlood PressureChronotherapyHumansRisk FactorsAntihypertensive Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.